Among them, TAM can inhibit the binding of normal progesterone, estrogen, and receptors in the body by binding to the epidermal hormone receptors of BC cells, thus preventing tumor growth [18, 19], while LTZ can restrain the growth of estrogen-dependent BC cells via inhibiting aromatase activity [20]. Here, CYP19A1 is linked to breast cancer.